This study applies a clinical risk assessment tool (COVID-GRAM) developed in China to a population of patients hospitalized with COVID-19 in Spain to evaluate the tool’s usefulness in Europe.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022262 | PMC |
http://dx.doi.org/10.1001/jamainternmed.2021.0491 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!